The current financial score of Rafael Holdings Inc is 6.57. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 179.00K, representing a year-over-year decrease of 50.55%, while its net profit experienced a year-over-year decrease of 11.57%.
The current valuation score of Rafael Holdings Inc is 6.28. Its current P/E ratio is -2.62, which is -887.82% below the recent high of 20.66 and -1060.95% above the recent low of -30.44.
No earnings forecast score is currently available for Rafael Holdings Inc. The Pharmaceuticals industry's average is 7.86.
The current price momentum score of Rafael Holdings Inc is 6.48. Currently, the stock price is trading between the resistance level at 2.63 and the support level at 1.66, making it suitable for range-bound swing trading.
The current institutional shareholding score of Rafael Holdings Inc is 3.00. The latest institutional shareholding proportion is 6.96%, representing a quarter-over-quarter decrease of 4.83%. The largest institutional shareholder is Irving Kahn, holding a total of 58.56K shares, representing 0.01% of shares outstanding, with 4.82% increase in holdings.
The current risk assessment score of Rafael Holdings Inc is 2.70. The company's beta value is 0.54. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.